Sánchez-Martínez LC, Paredes-Solís CA, Hernández-Ordóñez OF, Sánchez-Ruvalcaba IR

Language: Spanish
References: 6
Page: 124-126
PDF size: 47.88 Kb.

ABSTRACT

Prostate cancer (PC) is a common malignant neoplasia in males over 50 years. The serum level of prostate specific antigen (PSA) is a tool in the diagnosis of PC and benign prostatic hyperplasia patients that improves the efficiency obtained with the digital rectal examination. The use of PSA increases the detection rates of organ-confined PC. The PSA must be requested by the primary care physician in male population over 45 years and if the result is above the normal levels, the patient must be send to an urologist.

REFERENCES

1. Wang MC, Valenzuela LA, Murphy GP, Chu TM. Purification of a human prostate specific antigen. Invest Urol. 1979;17(2):159-63.

2. Hara M, Koyanagi Y, Inoue T, Fukuyama T. Some physicochemical characteristics of “gammaseminoprotein,” an antigenic component specific for human seminal plasma. Forensic immunological study of body fluids and secretion VII. Nihon Hoigaku Zasshi. 1971;25(4):322-4.

3. Instituto Nacional de Estadística. [Sitio web]. Defunciones según la causa de muerte. Año 2004. Madrid: INE. Disponible en http://www.ine.es/

4. Denmeade SR, Isaacs JT. A history of prostate cancer treatment. Nat Rev Cancer. 2002;2:389-96.

5. Wein A. Campbell-Walsh Urología. Décima edición. Buenos Aires: Médica Panamericana; 2010.

6. Hodge KK, McNeal JE, Terris MK, Stamey TA. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol. 1989;142(1):74-5.